The potential of CpG oligodeoxynucleotides as mucosal adjuvants.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001427:Bacterial Toxins / Q000008:administration & dosage; D006801:Humans; D018928:Immunity, Mucosal; D007114:Immunization; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D014018:Tissue Distribution; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology